Agios Stock Rebounds After Mitapivat Hits Key Target in Thalassemia Trial (NASDAQ:AGIO) by Technical Terrence Team 01/03/2024 0 Agios Pharmaceuticals (NASDAQ: AGIO) stocks rose ~33% premarket on Wednesday after a late-stage global trial of mitapivat in adults with ...
General Mills Non-GAAP EPS of $1.25 Beats $0.09, Revenue of $5.1 Billion Misses $260 Million (NYSE:GIS) 12/20/2023